The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D07 | Corticosteroids, dermatological preparations | |
| 3 | D07A | Corticosteroids, plain | |
| 4 | D07AB | Corticosteroids, moderately potent (group II) | |
| 5 | D07AB01 | Clobetasone |
| Active Ingredient | Description | |
|---|---|---|
| Clobetasone |
Clobetasone is a topical corticosteroids. Clobetasone has little effect on hypothalamo-pituitary-adrenal function. Clobetasone is less potent than other available corticosteroid preparations and has been shown not to suppress the hypothalamo-pituitary-adrenal axis in patients treated for psoriasis or eczema. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| EUMOVATE Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
